Contemporary management of atrial fibrillation: Update on anticoagulation and invasive management strategies

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Its increasing prevalence, particularly among the elderly, renders it one of the most serious current medical epidemics. Several management questions confront the clinician treating a patient with AF: Should the condition be treated? Is the patient at risk of death or serious morbidity as a result of this diagnosis? If treatment is necessary, is rate control or rhythm control superior? Which patients need anticoagulation therapy, and for how long? This review of articles obtained by a search of the PubMed and MEDLINE databases presents the available evidence that can guide the clinician in answering these questions. After discussing the merits of available therapy, including medications aimed at controlling rate, rhythm, or both, we focus on the present status of ablative therapy for AF. Catheter ablation, particularly targeting the pulmonary veins, is being increasingly performed, although the precise indications for this approach and its effectiveness and safety are being actively investigated. We briefly discuss other invasive options that are less frequently used, such as pacemakers, defibrillators, left atrial appendage closure devices, and the surgical maze procedure.

Original languageEnglish (US)
Pages (from-to)643-662
Number of pages20
JournalMayo Clinic Proceedings
Volume84
Issue number7
DOIs
StatePublished - 2009

Fingerprint

Atrial Fibrillation
Atrial Appendage
Defibrillators
Catheter Ablation
Pulmonary Veins
Therapeutics
PubMed
MEDLINE
Cardiac Arrhythmias
Databases
Morbidity
Safety
Equipment and Supplies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{685548713e4343b59e7e9852d0f702ad,
title = "Contemporary management of atrial fibrillation: Update on anticoagulation and invasive management strategies",
abstract = "Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Its increasing prevalence, particularly among the elderly, renders it one of the most serious current medical epidemics. Several management questions confront the clinician treating a patient with AF: Should the condition be treated? Is the patient at risk of death or serious morbidity as a result of this diagnosis? If treatment is necessary, is rate control or rhythm control superior? Which patients need anticoagulation therapy, and for how long? This review of articles obtained by a search of the PubMed and MEDLINE databases presents the available evidence that can guide the clinician in answering these questions. After discussing the merits of available therapy, including medications aimed at controlling rate, rhythm, or both, we focus on the present status of ablative therapy for AF. Catheter ablation, particularly targeting the pulmonary veins, is being increasingly performed, although the precise indications for this approach and its effectiveness and safety are being actively investigated. We briefly discuss other invasive options that are less frequently used, such as pacemakers, defibrillators, left atrial appendage closure devices, and the surgical maze procedure.",
author = "Crandall, {Mark A.} and Bradley, {David John} and Packer, {Douglas L} and Asirvatham, {Samuel J}",
year = "2009",
doi = "10.4065/84.7.643",
language = "English (US)",
volume = "84",
pages = "643--662",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "7",

}

TY - JOUR

T1 - Contemporary management of atrial fibrillation

T2 - Update on anticoagulation and invasive management strategies

AU - Crandall, Mark A.

AU - Bradley, David John

AU - Packer, Douglas L

AU - Asirvatham, Samuel J

PY - 2009

Y1 - 2009

N2 - Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Its increasing prevalence, particularly among the elderly, renders it one of the most serious current medical epidemics. Several management questions confront the clinician treating a patient with AF: Should the condition be treated? Is the patient at risk of death or serious morbidity as a result of this diagnosis? If treatment is necessary, is rate control or rhythm control superior? Which patients need anticoagulation therapy, and for how long? This review of articles obtained by a search of the PubMed and MEDLINE databases presents the available evidence that can guide the clinician in answering these questions. After discussing the merits of available therapy, including medications aimed at controlling rate, rhythm, or both, we focus on the present status of ablative therapy for AF. Catheter ablation, particularly targeting the pulmonary veins, is being increasingly performed, although the precise indications for this approach and its effectiveness and safety are being actively investigated. We briefly discuss other invasive options that are less frequently used, such as pacemakers, defibrillators, left atrial appendage closure devices, and the surgical maze procedure.

AB - Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Its increasing prevalence, particularly among the elderly, renders it one of the most serious current medical epidemics. Several management questions confront the clinician treating a patient with AF: Should the condition be treated? Is the patient at risk of death or serious morbidity as a result of this diagnosis? If treatment is necessary, is rate control or rhythm control superior? Which patients need anticoagulation therapy, and for how long? This review of articles obtained by a search of the PubMed and MEDLINE databases presents the available evidence that can guide the clinician in answering these questions. After discussing the merits of available therapy, including medications aimed at controlling rate, rhythm, or both, we focus on the present status of ablative therapy for AF. Catheter ablation, particularly targeting the pulmonary veins, is being increasingly performed, although the precise indications for this approach and its effectiveness and safety are being actively investigated. We briefly discuss other invasive options that are less frequently used, such as pacemakers, defibrillators, left atrial appendage closure devices, and the surgical maze procedure.

UR - http://www.scopus.com/inward/record.url?scp=67650755000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650755000&partnerID=8YFLogxK

U2 - 10.4065/84.7.643

DO - 10.4065/84.7.643

M3 - Article

C2 - 19567719

AN - SCOPUS:67650755000

VL - 84

SP - 643

EP - 662

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 7

ER -